Company
Minerva Neurosciences, Inc. (NERV)
Standardized SEC financial data for Minerva Neurosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001598646 · NASDAQ · Pharmaceutical Preparations.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $41.2M | $0 | $0 | $0 | $0 | — |
| R&D expense | $22.0M | $32.0M | $14.6M | $12.7M | $11.9M | $5.8M |
| SG&A expense | $17.3M | $13.3M |
Standardized from Minerva Neurosciences, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.5M | $60.9M | $36.2M | $41.0M | $21.5M | $82.4M |
| Total current assets |
Get NERV data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NERV/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NERV/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"